A Study to Evaluate the Long-term Safety and Efficacy of Long-acting Antibodies as Single Agents and in Combinations in Participants With Inflammatory Bowel Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07652294

Title field or adapter rule

{'original_value': 'A Study to Evaluate the Long-term Safety and Efficacy of Long-acting Antibodies as Single Agents and in Combinations in Participants With Inflammatory Bowel Disease', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:36.132798+00:00

Published At

2026-10-27T00:00:00+00:00

Record Updated At

2026-10-27

Source Retrieved At

2026-10-31T22:18:58.295941+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Ulcerative Colitis", "Inflammatory Bowel Diseases", "Colitis", "Colitis, Ulcerative"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-27", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07652294"

protocolSection.identificationModule.officialTitle

"A Study to Evaluate the Long-term Safety and Efficacy of Long-acting Antibodies as Single Agents and in Combinations in Participants With Inflammatory Bowel Disease"

protocolSection.statusModule.overallStatus

"ENROLLING_BY_INVITATION"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Ulcerative Colitis (protocolSection.conditionsModule.conditions)
• Inflammatory Bowel Diseases (protocolSection.conditionsModule.conditions)
• Colitis (protocolSection.conditionsModule.conditions)
• Colitis, Ulcerative (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['SPY001 & SPY002', 'SPY001 & SPY003', 'SPY001 Dosing Regimen 1', 'SPY001 Dosing Regimen 2'], 'description': 'Experimental', 'name': 'SPY001', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['SPY001 & SPY002', 'SPY002 & SPY003', 'SPY002 Dosing Regimen 1', 'SPY002 Dosing Regimen 2', 'SPY002 Dosing Regimen 3'], 'description': 'Experimental', 'name': 'SPY002', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['SPY001 & SPY003', 'SPY002 & SPY003', 'SPY003 Dosing Regimen 1', 'SPY003 Dosing Regimen 2'], 'description': 'Experimental', 'name': 'SPY003', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• SPY001 (protocolSection.armsInterventionsModule.interventions[].name)
• SPY002 (protocolSection.armsInterventionsModule.interventions[].name)
• SPY003 (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.